Valuation: MiniMed Group, Inc.

Market Cap 5.42B 4.85B 4.48B 4.05B 7.57B 516B 7.7B 53.39B 21.3B 270B 20.33B 19.89B 855B P/E 2027 *
29.3x
P/E 2028 * 25.3x
Enterprise Value 5.15B 4.61B 4.25B 3.85B 7.2B 490B 7.31B 50.74B 20.24B 256B 19.32B 18.9B 812B EV / Sales 2027 *
1.5x
EV / Sales 2028 * 1.3x
Free-Float
99.88%
Yield 2027 *
-
Yield 2028 * -
1 day+0.21%
1 week+5.25%
Current month-1.13%
1 month-3.94%
3 months+4.62%
6 months+60.15%
1 week 18.07
Extreme 18.07
19.55
1 month 16.56
Extreme 16.555
20.17
Current year 10.65
Extreme 10.65
24.43
1 year 10.65
Extreme 10.65
24.43
3 years 10.65
Extreme 10.65
24.43
5 years 10.65
Extreme 10.65
24.43
10 years 10.65
Extreme 10.65
24.43
Date Insider Type Main position Quantity % Market Cap. Importance
10/15/26 A Free

Director

11,877 0.0042%
10/15/26 A Free

Director

3,374 0.0012%
10/15/26 A Free

Director

11,877 0.0042%
Change 5-day change 1-year change 3-year change Capi.($)
+0.21%+5.25% - - 5.42B
+1.88%+2.01%-15.96%+12.62% 181B
+2.55%+1.52%-15.65%+19.03% 120B
+2.46%+0.54%+5.87%+39.87% 119B
+0.28%+0.59%-44.02%+6.06% 91.44B
+1.91%-2.35%-0.79%+76.15% 63.07B
-0.46%+0.42%+8.19%+82.97% 55.8B
+1.63%-1.04%+9.27%-21.17% 54.03B
+2.32%+1.63%-8.23%+47.17% 45.38B
+1.94%+1.59%-1.11%-6.94% 34.37B
Average +1.23%+0.96%-6.94%+28.42% 76.89B
Weighted average by Cap. +1.34%+0.79%-9.94%+26.25%

Financials

2027 *2028 *
Net sales 3.44B 3.08B 2.84B 2.57B 4.8B 327B 4.88B 33.87B 13.51B 171B 12.89B 12.62B 542B 3.73B 3.34B 3.08B 2.79B 5.21B 355B 5.3B 36.75B 14.66B 186B 13.99B 13.69B 588B
Net income 186M 166M 154M 139M 260M 17.69B 264M 1.83B 731M 9.26B 697M 682M 29.33B 239M 214M 198M 179M 334M 22.78B 340M 2.36B 941M 11.92B 898M 878M 37.75B
Net Debt -269M -241M -223M -201M -377M -25.64B -383M -2.65B -1.06B -13.42B -1.01B -989M -42.51B -583M -523M -482M -436M -816M -55.56B -829M -5.75B -2.29B -29.08B -2.19B -2.14B -92.1B
Projected Income Statement - Annual - MiniMed Group, Inc.
Logo MiniMed Group, Inc.
MiniMed Group, Inc. is an insulin delivery company advancing automated therapy for people with diabetes. Its fully integrated system addresses pain points for people with diabetes (PWD): health outcomes and complexity of diabetes management. The MiniMed 780G is its flagship AID system. The MiniMed 780G system uses its SmartGuard dosing algorithm technology, which automatically delivers basal insulin and auto-correction doses every five minutes based on sensor glucose readings. The MiniMed 780G consists of the MiniMed 780G insulin pump, the Simplera Sync CGM sensor, and the instinct sensor. Its platform of clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and a Smart Multiple Daily Injection (MDI) System. Its pipeline products are the MiniMed Flex, screenless insulin pump, next-generation Vivera dosing algorithm, and MiniMed Fit patch pump with extended wear.
Employees
-
Date Price Change Volume
29/10/26 $19.25 +0.21% 7,334,548
28/10/26 $19.21 +1.48% 10,305,392
27/10/26 $18.93 +1.45% 8,001,490
26/10/26 $18.66 +1.74% 5,289,813
23/10/26 $18.34 +0.27% 4,801,656
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - MiniMed Group, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
19.25USD
Average target price
25.47USD
Spread / Average Target
+32.29%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - MiniMed Group, Inc.
  1. Stock Market
  2. Stocks
  3. MMED Stock